SYS-CON MEDIA Authors: Unitiv Blog, Kevin Benedict, Maxime Charlès, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

Women In Government Launches a Pulmonary Hypertension Legislative Toolkit

WASHINGTON, Jan. 3, 2014 /PRNewswire-iReach/ -- Women In Government (WIG) today announced the launch of its Pulmonary Hypertension Legislative Toolkit, designed to provide information and resources regarding Pulmonary Hypertension (PH) for women state legislators.


Each year, 10 to 15 million people are diagnosed with pulmonary hypertension, 200,000 are hospitalized, and more than 15,000 die of the disease.

"Pulmonary Hypertension is a serious disease, but with increased awareness, early detection, and proper treatment we can decrease hospitalization time, and increase survival rates," said Marjorie Maginn, WIG President and Executive Director. "Women In Government encourages state legislators to familiarize themselves with this disease so that they can protect their constituents and ensure a healthier community."

Inside the Pulmonary Hypertension Legislative Toolkit, viewers will find information regarding the following: facts and statistics; frequently asked questions; a glossary of terms related to PH; sample legislation; awareness and action items; a sample Op/Ed; a sample constituent letter; a sample colleague letter; a PowerPoint with PH information; and a list of resources and partners. To view the Pulmonary Hypertension Legislative Toolkit visit

Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization serving approximately 1790 women state legislators, and providing leadership opportunities, networking, expert forums, and educational resources. For more information, visit or follow us on Facebook and Twitter.

Media Contact: Dyan Alexander, Women In Government, 2023330825, [email protected]

News distributed by PR Newswire iReach:

SOURCE Women In Government

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.